Omnicell (OMCL) Net Cash Flow Growth (3y) (2013 - 2026)
Omnicell (OMCL) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 33.04 Bn | 25.73 Bn | 662.02 Mn | 31.95% |
| 2 | Healthequity | 8.57 Bn | 8.30 Bn | 256.31 Mn | -23.22% |
| 3 | 10x Genomics | 5.94 Bn | 5.40 Bn | 106.18 Mn | -47.37% |
| 4 | Hinge Health | 5.91 Bn | 5.59 Bn | 154.23 Mn | - |
| 5 | MiniMed | 4.63 Bn | 4.33 Bn | 480.00 Mn | - |
| 6 | Waystar Holding | 4.61 Bn | 4.55 Bn | 216.84 Mn | - |
| 7 | Doximity | 4.02 Bn | 3.27 Bn | 125.97 Mn | 92.69% |
| 8 | Privia Health | 3.09 Bn | 2.67 Bn | - | -17.84% |
| 9 | Omnicell | 1.94 Bn | 1.70 Bn | 140.36 Mn | 139.35% |
| 10 | Teladoc Health | 1.64 Bn | 892.71 Mn | 416.32 Mn | -0.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.35% |
| Dec 31, 2025 | -28.50% |
| Sep 30, 2025 | -153.76% |
| Jun 30, 2025 | 41.98% |
| Mar 31, 2025 | 30.31% |
| Dec 31, 2024 | -14.98% |
| Sep 30, 2024 | 28.02% |
| Jun 30, 2024 | -24.10% |
| Mar 31, 2024 | -6.12% |
| Dec 31, 2023 | 31.62% |
| Sep 30, 2023 | -54.82% |
| Jun 30, 2023 | 27.84% |
| Mar 31, 2023 | 28.75% |
| Dec 31, 2022 | 103.72% |
| Sep 30, 2022 | -34.12% |
| Jun 30, 2022 | -54.39% |
| Mar 31, 2022 | -107.60% |
| Dec 31, 2021 | -93.83% |
| Sep 30, 2021 | -396.26% |
| Jun 30, 2021 | 174.65% |